A new study of outcomes among more than 33,000 hospitalized COVID-19 patients shows that remdesivir plus dexamethasone ...
While XEC is not dominant in the United States, it could take hold by the late fall and winter, one health expert said in a ...
The coronavirus subvariant XEC is drawing more attention as a potential threat heading into late autumn and winter — ...
In reality, the vaccinations have been tested and provide updated protection from new coronavirus variants. They have been ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
The coronavirus subvariant XEC is drawing more attention as a potential threat heading into late autumn and winter — ...
The evidence that FFP3 masks were more protective for doctors than surgical masks is ‘weak’, the Covid inquiry has heard.